Log In or Register to Join The Conversation!

This topic has 0 replies, 1 voice, and was last updated 2 years, 5 months ago by Kevin Schaefer.

  • Author
    • #15781
      Kevin Schaefer

      In this episode of the SMA News Today Podcast, I talk with Forums Director Michael Morale about the pharmaceutical company AveXis, and its recent filing for FDA approval of the therapy AVXS-101. This treatment is designed for infants with SMA Type I.

      During this discussion, Michael and I talk about when this treatment could be made available, if it will eventually be available for adults with SMA, what it means for SMA patients who are already on Spinraza (nusinersen), and what other treatments for SMA are in development.

      Michael and I will be doing these roundtable discussions monthly, and we will tackle a wide range of subjects pertaining to the SMA community. Be sure to subscribe to the SMA News Today Podcast, and share your thoughts in the comments.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account

Copyright © 2017-2021 All rights reserved.